Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence

被引：191

作者：

Rossing, Peter ^{[1
,2
]}

Caramori, M. Luiza ^{[3
]}

Chan, Juliana C. N. ^{[4
,5
]}

Heerspink, Hiddo J. L. ^{[6
]}

Hurst, Clint

Khunti, Kamlesh ^{[7
]}

Liew, Adrian ^{[8
]}

Michos, Erin D. ^{[9
]}

Navaneethan, Sankar D. ^{[10
,11
]}

Olowu, Wasiu A. ^{[12
]}

Sadusky, Tami

Tandon, Nikhil ^{[13
]}

Tuttle, Katherine R. ^{[14
]}

Wanner, Christoph ^{[15
]}

Wilkens, Katy G. ^{[16
]}

Zoungas, Sophia ^{[17
]}

Craig, Jonathan C. ^{[18
,19
]}

Tunnicliffe, David J. ^{[19
,20
]}

Tonelli, Marcello A. ^{[21
]}

Cheung, Michael ^{[22
]}

Earley, Amy ^{[22
]}

de Boer, Ian H. ^{[23
]}

机构：

[1] Steno Diabet Ctr Copenhagen, Copenhagen, Denmark

[2] Univ Copenhagen, Copenhagen, Denmark

[3] Univ Minnesota, Div Diabet Endocrinol & Metab, Minneapolis, MN USA

[4] Hong Kong Inst Diabet & Obes, Dept Med & Therapeut, Hong Kong, Peoples R China

[5] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China

[6] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands

[7] Univ Leicester, Leicester Gen Hosp, Diabet Res Ctr, Leicester, Leics, England

[8] Mt Elizabeth Novena Hosp, Kidney & Transplant Practice, Singapore, Singapore

[9] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA

[10] Baylor Coll Med, Dept Med, Selzman Inst Kidney Hlth, Sect Nephrol, Houston, TX 77030 USA

[11] Michael & DeBakey Vet Affairs Med Ctr, Sect Nephrol, Houston, TX USA

[12] Obafemi Awolowo Univ Teaching Hosp Complex, Pediat Nephrol & Hypertens Unit, Ife, State Of Osun, Nigeria

[13] All India Inst Med Sci, Dept Endocrinol & Metab, New Delhi, India

[14] Univ Washington, Div Nephrol, Spokane, WA USA

[15] Univ Hosp Wurzburg, Div Nephrol, Wurzburg, Germany

[16] Northwest Kidney Ctr, Nutr & Fitness Serv, Seattle, WA USA

[17] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia

[18] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia

[19] Cochrane Kidney & Transplant, Sydney, NSW, Australia

[20] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia

[21] Univ Calgary, Dept Med, Calgary, AB, Canada

[22] KDIGO, Brussels, Belgium

[23] Univ Washington, Kidney Res Inst, Box 359606,325 9th Ave, Seattle, WA 98104 USA

来源：

KIDNEY INTERNATIONAL | 2022年 / 102卷 / 05期

关键词：

INTENSIFIED MULTIFACTORIAL INTERVENTION; TYPE-2; RISK; MICROALBUMINURIA; SPIRONOLACTONE; CANAGLIFLOZIN; MORTALITY; PEOPLE;

D O I：

10.1016/j.kint.2022.06.013

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：990 / 999

页数：10